Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 5 studies | 51% ± 26% | |
| adipocyte | 3 studies | 18% ± 2% | |
| GABAergic neuron | 3 studies | 52% ± 12% | |
| astrocyte | 3 studies | 31% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 43% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 240.14 | 245 / 245 | 34% | 0.53 | 173 / 502 |
| adrenal gland | 99% | 152.66 | 255 / 258 | 19% | 0.30 | 43 / 230 |
| brain | 100% | 267.61 | 2638 / 2642 | 18% | 0.28 | 124 / 705 |
| breast | 100% | 272.12 | 459 / 459 | 15% | 0.25 | 168 / 1118 |
| ovary | 100% | 121.96 | 180 / 180 | 9% | 0.15 | 38 / 430 |
| uterus | 99% | 121.73 | 168 / 170 | 5% | 0.11 | 21 / 459 |
| bladder | 100% | 92.71 | 21 / 21 | 1% | 0.03 | 6 / 504 |
| thymus | 100% | 118.41 | 652 / 653 | 1% | 0.01 | 6 / 605 |
| skin | 99% | 119.76 | 1782 / 1809 | 2% | 0.07 | 10 / 472 |
| spleen | 100% | 117.57 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 260.36 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 97% | 96.61 | 86 / 89 | 2% | 0.02 | 14 / 901 |
| blood vessel | 98% | 112.75 | 1309 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 96% | 77.36 | 345 / 359 | 0% | 0.00 | 1 / 286 |
| intestine | 95% | 99.10 | 915 / 966 | 2% | 0.03 | 8 / 527 |
| lung | 94% | 86.29 | 545 / 578 | 1% | 0.02 | 16 / 1155 |
| esophagus | 93% | 92.10 | 1351 / 1445 | 1% | 0.01 | 1 / 183 |
| pancreas | 89% | 63.66 | 293 / 328 | 1% | 0.01 | 2 / 178 |
| liver | 81% | 50.94 | 183 / 226 | 4% | 0.08 | 16 / 406 |
| muscle | 85% | 62.84 | 680 / 803 | 0% | 0 | 0 / 0 |
| heart | 83% | 67.62 | 714 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 30% | 21.84 | 275 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0000724 | Biological process | double-strand break repair via homologous recombination |
| GO_0019985 | Biological process | translesion synthesis |
| GO_0036297 | Biological process | interstrand cross-link repair |
| GO_0006261 | Biological process | DNA-templated DNA replication |
| GO_0006302 | Biological process | double-strand break repair |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0003887 | Molecular function | DNA-directed DNA polymerase activity |
| GO_0003677 | Molecular function | DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0030332 | Molecular function | cyclin binding |
| Gene name | POLN |
| Protein name | DNA polymerase nu DNA polymerase nu (EC 2.7.7.7) |
| Synonyms | |
| Description | FUNCTION: DNA polymerase with very low fidelity that catalyzes considerable misincorporation by inserting dTTP opposite a G template, and dGTP opposite a T template . Is the least accurate of the DNA polymerase A family (i.e. POLG, POLN and POLQ) . Can perform accurate translesion DNA synthesis (TLS) past a 5S-thymine glycol. Can perform efficient strand displacement past a nick or a gap and gives rise to an amount of product similar to that on non-damaged template. Has no exonuclease activity . Error-prone DNA polymerase that preferentially misincorporates dT regardless of template sequence . May play a role in TLS during interstrand cross-link (ICL) repair . May be involved in TLS when genomic replication is blocked by extremely large major groove DNA lesions. May function in the bypass of some DNA-protein and DNA-DNA cross-links. May have a role in cellular tolerance to DNA cross-linking agents . Involved in the repair of DNA cross-links and double-strand break (DSB) resistance. Participates in FANCD2-mediated repair. Forms a complex with HELQ helicase that participates in homologous recombination (HR) repair and is essential for cellular protection against DNA cross-links . . |
| Accessions | ENST00000511098.1 ENST00000382865.5 [Q7Z5Q5-1] Q7Z5Q5 ENST00000511885.6 [Q7Z5Q5-1] H0YA88 |